These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 25620152

  • 1. Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.
    Khurshid S, Akerman S, Man JP, Supple G, Dixit S, Epstein AE, Marchlinski FE, Frankel DS.
    J Interv Card Electrophysiol; 2015 Mar; 42(2):117-24. PubMed ID: 25620152
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation.
    Steinberg JS, Shah Y, Szepietowska B.
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):667-671. PubMed ID: 28220940
    [Abstract] [Full Text] [Related]

  • 3. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
    Coleman CI, Sood N, Chawla D, Talati R, Ghatak A, Kluger J, Dofetilide and Intravenous Magnesium Evaluation (DIME) Investigators.
    Europace; 2009 Jul; 11(7):892-5. PubMed ID: 19351630
    [Abstract] [Full Text] [Related]

  • 4. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
    Huang HD, Waks JW, Steinhaus DA, Zimetbaum P.
    Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter.
    Banchs JE, Wolbrette DL, Samii SM, Penny-Peterson ED, Patel PP, Young SK, Gonzalez MD, Naccarelli GV.
    J Interv Card Electrophysiol; 2008 Nov; 23(2):111-5. PubMed ID: 18688699
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL, Wachtell K, Christensen PD, Madsen B, Johansen JB, Christiansen EH, Graff O, Simonsen EH.
    Am Heart J; 1999 Jun; 137(6):1062-9. PubMed ID: 10347332
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
    Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp-Pedersen C.
    Circulation; 2001 Jul 17; 104(3):292-6. PubMed ID: 11457747
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.
    Malhotra R, Bilchick KC, DiMarco JP.
    Am J Cardiol; 2014 Feb 01; 113(3):475-9. PubMed ID: 24321897
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD.
    Congenit Heart Dis; 2014 Feb 01; 9(3):221-7. PubMed ID: 23947935
    [Abstract] [Full Text] [Related]

  • 10. Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.
    Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M, Janiszewski D, Lindsay B, Militello M, Nissen SE, Poe S, Tanaka-Esposito C, Wolski K, Wilkoff BL.
    Circ Arrhythm Electrophysiol; 2015 Aug 01; 8(4):772-6. PubMed ID: 26063741
    [Abstract] [Full Text] [Related]

  • 11. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
    Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Kowey PR.
    J Cardiovasc Electrophysiol; 2012 May 01; 23(5):462-72. PubMed ID: 22171925
    [Abstract] [Full Text] [Related]

  • 12. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A.
    Int J Clin Pract; 2007 May 01; 61(5):748-56. PubMed ID: 17493088
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
    Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB.
    Circulation; 2000 Nov 07; 102(19):2385-90. PubMed ID: 11067793
    [Abstract] [Full Text] [Related]

  • 14. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 15. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D, Rostock T, Fröhlich M, Sultan A, Servatius H, Hoffmann BA, Lüker J, Berner I, Schäffer B, Wegscheider K, Lezius S, Willems S, Steven D.
    Circ Arrhythm Electrophysiol; 2015 Apr 18; 8(2):308-17. PubMed ID: 25744570
    [Abstract] [Full Text] [Related]

  • 16. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L, Castro A, Dinelli M, Alboni P, Pappalardo A, Richiardi E, Santini M.
    Eur Heart J; 2000 Aug 18; 21(15):1265-73. PubMed ID: 10924317
    [Abstract] [Full Text] [Related]

  • 17. Acute conversion of persistent atrial fibrillation during dofetilide initiation.
    Cotiga D, Arshad A, Aziz E, Joshi S, Koneru JN, Steinberg JS.
    Pacing Clin Electrophysiol; 2007 Dec 18; 30(12):1527-30. PubMed ID: 18070309
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K.
    J Heart Lung Transplant; 2006 Jan 18; 25(1):53-60. PubMed ID: 16399531
    [Abstract] [Full Text] [Related]

  • 19. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ, Markham A.
    Drugs; 1999 Dec 18; 58(6):1043-59. PubMed ID: 10651390
    [Abstract] [Full Text] [Related]

  • 20. Frequency of toxicity with chemical conversion of atrial fibrillation with dofetilide.
    Brumberg G, Gera N, Pray C, Adelstein E, Barrington W, Bazaz R, Mendenhall GS, Nemec J, Voigt A, Wang NC, Schwartzman D, Saba S, Jain SK.
    Am J Cardiol; 2013 Aug 15; 112(4):505-8. PubMed ID: 23706388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.